Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Prognostic Impact Of Baseline Tumor Size (Bts) On Survival Outcomes In Patients (Pts) With Untreated Advanced Nonsmall Cell Lung Cancer (Nsclc), Pd-L1 >= 50%, Treated With Pembrolizumab Alone

M. Bureau, T. Chatelier,T. Perennec,T. Goronflot, C. Greilsamer, A-L. Chene, R. Affi,J. Bennouna,E. Pons-Tostivint

ANNALS OF ONCOLOGY（2021）

Cited 0|Views4
No score
Abstract
Pembrolizumab for pts with untreated advanced NSCLC PD-L1 ≥50% is a chemotherapy-free option. Data suggest that those with high tumour burden derive moderate benefits from pembrolizumab. We conducted a retrospective study to assess the impact of BTS on overall survival (OS) in untreated NSCLC pts treated with pembrolizumab or chemotherapy.
More
Translated text
Key words
cell lung cancer,lung cancer,baseline tumor size,pembrolizumab,survival outcomes,non-small
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined